TrialJAMA neurology2018

Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.

Michael S Rafii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.